ADBiotech Co., Ltd. (KOSDAQ:179530)

Market Cap	20.07B
Revenue (ttm)	11.14B
Net Income (ttm)	-7.95B
Shares Out	11.36M
EPS (ttm)	-870.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,917
Average Volume	65,401
Open	1,779.00
Previous Close	1,762.00
Day's Range	1,700.00 - 1,804.00
52-Week Range	1,351.00 - 4,675.00
Beta	1.03
RSI	52.08
Earnings Date	May 14, 2025

About ADBiotech

ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally. The company offers antibiotic, disinfectant, helminthic, over the counter drugs, supplementary feed, and metabolic drugs. It also offers health functional and processed foods. ADBiotech Co., Ltd. was founded in 2000 and is based in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 179530

Financial Performance

In 2024, ADBiotech's revenue was 11.14 billion, an increase of 6.34% compared to the previous year's 10.47 billion. Losses were -7.95 billion, 177.7% more than in 2023.